Literature DB >> 10930222

Pathomorphological and histological prognostic factors in curatively resected ductal adenocarcinoma of the pancreas.

W Meyer1, C Jurowich, M Reichel, B Steinhäuser, P H Wünsch, C Gebhardt.   

Abstract

The fate of patients with potentially resectable carcinomas is not only determined by the pTNM tumor stage, but also possibly by tumor-biological factors. The aim of this study was to identify these prognostic factors in patients undergoing primary curative (R0) resection. The study retrospectively analyzed 113 patients with ductal adenocarcinoma who were operated on between 1986 and 1995. R0 resection was able to be performed in 93 patients. Lymph node metastases were found in 73%. The rates of lymph vessel and perineural invasion were 83.5% and 45%, respectively. Among the 25 carcinomas without lymph node metastases, 64% already had lymph vessel invasion and 48% had perineural invasion. The cumulative 5-year survival rate of the 91 surviving patients analyzed was 10.5%. Depending on the tumor stage we found a significant difference in 5-year survival rates between patients without lymph node metastases (26.5%) and those with lymph node involvement (5%) (P = 0.008). A multivariate analysis only identified lymph vessel invasion (L0/1), tumor size (< or = or < or =2 cm), and tumor grading (G) to have significant and independent prognostic value. Lymph vessel invasion, tumor size, and tumor grading proved to be independent factors determining long-term prognosis.

Entities:  

Mesh:

Year:  2000        PMID: 10930222     DOI: 10.1007/s005950070096

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  25 in total

1.  Surgical curability and prognosis for standard versus extended resection for T1 carcinoma of the pancreas.

Authors:  K Satake; H Nishiwaki; H Yokomatsu; Y Kawazoe; K Kim; A Haku; K Umeyama; I Miyazaki
Journal:  Surg Gynecol Obstet       Date:  1992-09

2.  Surgical treatment of ductal pancreatic carcinoma.

Authors:  F P Gall; H Kessler; P Hermanek
Journal:  Eur J Surg Oncol       Date:  1991-04       Impact factor: 4.424

3.  Ductal adenocarcinoma of the head of the pancreas: incidence of tumor involvement beyond the Whipple resection line. Histological and immunocytochemical analysis of 37 total pancreatectomy specimens.

Authors:  G Klöppel; T Lohse; K Bosslet; K Rückert
Journal:  Pancreas       Date:  1987       Impact factor: 3.327

4.  Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer.

Authors:  J L Cameron; D W Crist; J V Sitzmann; R H Hruban; J K Boitnott; A J Seidler; J Coleman
Journal:  Am J Surg       Date:  1991-01       Impact factor: 2.565

5.  Factors influencing survival after resection of pancreatic cancer. A DNA analysis and a histomorphologic study.

Authors:  T C Böttger; S Störkel; S Wellek; M Stöckle; T Junginger
Journal:  Cancer       Date:  1994-01-01       Impact factor: 6.860

6.  Clinicopathologic features of small pancreatic adenocarcinoma. A collective study.

Authors:  H Furukawa; S Okada; H Saisho; J Ariyama; E Karasawa; A Nakaizumi; S Nakazawa; K Murakami; T Kakizoe
Journal:  Cancer       Date:  1996-09-01       Impact factor: 6.860

7.  [The biological behavior of exocrine pancreatic carcinoma from a pathological-anatomical viewpoint. A contribution to the problems of surgical therapy].

Authors:  O Reich; J Justus
Journal:  Zentralbl Chir       Date:  1991       Impact factor: 0.942

Review 8.  [Prognostic factors in pancreatic cancer].

Authors:  H Höfler
Journal:  Chirurg       Date:  1994-04       Impact factor: 0.955

9.  Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients.

Authors:  C J Yeo; J L Cameron; K D Lillemoe; J V Sitzmann; R H Hruban; S N Goodman; W C Dooley; J Coleman; H A Pitt
Journal:  Ann Surg       Date:  1995-06       Impact factor: 12.969

10.  Results of resection for cancer of the exocrine pancreas: a study from the French Association of Surgery.

Authors:  H Baumel; M Huguier; J C Manderscheid; J M Fabre; S Houry; H Fagot
Journal:  Br J Surg       Date:  1994-01       Impact factor: 6.939

View more
  18 in total

1.  The role of MRI in pancreatic cancer.

Authors:  Philip A Robinson
Journal:  Eur Radiol       Date:  2001-10-16       Impact factor: 5.315

2.  Impact of margin status and lymphadenectomy on clinical outcomes in resected pancreatic adenocarcinoma: implications for adjuvant radiotherapy.

Authors:  Arsen Osipov; Jason Naziri; Andrew Hendifar; Deepti Dhall; Joanne K Rutgers; Shefali Chopra; Quanlin Li; Mourad Tighiouart; Alagappan Annamalai; Nicholas N Nissen; Richard Tuli
Journal:  J Gastrointest Oncol       Date:  2016-04

Review 3.  Re-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreas.

Authors:  Daniel Åkerberg; Daniel Ansari; Roland Andersson
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

4.  Prognostic implication of para-aortic lymph node metastasis in resectable pancreatic cancer.

Authors:  Ryuichiro Doi; Kazuhiro Kami; Daisuke Ito; Koji Fujimoto; Yoshiya Kawaguchi; Michihiko Wada; Masafumi Kogire; Ryo Hosotani; Masayuki Imamura; Shinji Uemoto
Journal:  World J Surg       Date:  2007-01       Impact factor: 3.352

5.  Multivariate statistical analysis of clinicopathologic factors influencing survival of patients with bile duct carcinoma.

Authors:  Ping He; Jin-Sen Shi; Wu-Ke Chen; Zuo-Ren Wang; Hong Ren; Hua Li
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

6.  Clinical significance of focal adhesion kinase in resectable pancreatic cancer.

Authors:  Kenichiro Furuyama; Ryuichiro Doi; Tomohiko Mori; Eiji Toyoda; Daisuke Ito; Kazuhiro Kami; Masayuki Koizumi; Atsushi Kida; Yoshiya Kawaguchi; Koji Fujimoto
Journal:  World J Surg       Date:  2006-02       Impact factor: 3.352

Review 7.  Survival after surgical management of pancreatic adenocarcinoma: does curative and radical surgery truly exist?

Authors:  H G Smeenk; T C K Tran; J Erdmann; C H J van Eijck; J Jeekel
Journal:  Langenbecks Arch Surg       Date:  2004-05-14       Impact factor: 3.445

8.  Surgery versus radiochemotherapy for resectable locally invasive pancreatic cancer: final results of a randomized multi-institutional trial.

Authors:  Ryuichiro Doi; Masayuki Imamura; Ryo Hosotani; Toshihide Imaizumi; Takashi Hatori; Ken Takasaki; Akihiro Funakoshi; Hideyuki Wakasugi; Takehide Asano; Shoichi Hishinuma; Yoshiro Ogata; Makoto Sunamura; Koji Yamaguchi; Masao Tanaka; Sonshin Takao; Takashi Aikou; Koichi Hirata; Hiroyuki Maguchi; Koichi Aiura; Tatsuya Aoki; Akira Kakita; Makoto Sasaki; Masahiko Ozaki; Satoru Matsusue; Shunichi Higashide; Hideki Noda; Seiyo Ikeda; Shunzo Maetani; Shigeaki Yoshida
Journal:  Surg Today       Date:  2008-10-29       Impact factor: 2.549

9.  Modeling prognostic factors in resectable pancreatic adenocarcinomas.

Authors:  Taxiarchis Botsis; Valsamo K Anagnostou; Gunnar Hartvigsen; George Hripcsak; Chunhua Weng
Journal:  Cancer Inform       Date:  2010-01-20

10.  Long-term survival and prognostic indicators in small (<or=2 cm) pancreatic cancer.

Authors:  Supot Pongprasobchai; Rahul Pannala; Thomas C Smyrk; William Bamlet; Suresh Pitchumoni; Andrei Ougolkov; Mariza de Andrade; Gloria M Petersen; Suresh T Chari
Journal:  Pancreatology       Date:  2008-10-13       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.